JP Morgan Maintains Overweight Rating On Thermo Fisher Scientific, Inc. (TMO)

Analysts at JP Morgan have released an update on Thermo Fisher Scientific, Inc. TMO. The company hosted its analyst meeting in New York City. The meeting touched on familiar themes including growth drivers for both divisions, benefits from cost containment initiatives, plans for expansion in Asia, growth from newer markets and a focus on operating leverage and capital deployment. The company also reiterated its guidance for 2010. Following the meeting, analysts at JP Morgan have maintained their Overweight rating and $60 price target for Thermo Fisher Scientific, Inc.